Laron syndrome presenting with severe low bone density for age in a 28-year-old woman: a case report
Open Access
- 10 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6792-6797
Abstract
Introduction: Laron syndrome (LS) is a rare, autosomal recessive disorder of growth hormone insensitivity, characterized by proportional short stature and low concentrations of insulin-like growth factor-1 (IGF-1) despite normal or increased levels of growth hormone. Case presentation: A 28-year-old woman presented with proportional short stature and a markedly low body weight, with a BMI of 14.5 kg/m 2 . Physical examination revealed a characteristic phenotype, including a prominent forehead, saddle-shaped nose and blue-tinted sclera. Investigations revealed low serum IGF-1 levels with elevated levels of growth hormone. Severe vitamin D deficiency and secondary hyperparathyroidism were observed. Differentials of malnutrition and clinical hypothyroidism were systematically ruled out. Management was focused on closed fracture reduction, vitamin D and calcium supplementation, and physical rehabilitation of the patient. Clinical discussion: Based on the phenotypic presentation and endocrine profile of the patient, a clinical diagnosis of LS was formulated. Unlike common LS presentations, this patient was markedly underweight, suggesting ethnic and nutritional variations. The comorbid vitamin D deficiency likely acted as a disease modifier, exacerbating the skeletal complications in an already compromised skeletal system. Conclusion: This case underscores the importance of strong clinical acumen in diagnosing rare growth disorders, especially in resource-limited settings where confirmatory genetic testing is not readily available. It also highlights how secondary bone disturbances can exacerbate the presentation, leading to significant functional impairment.Keywords
This publication has 19 references indexed in Scilit:
- Laron syndrome in three female siblings with the development of subclinical hypothyroidism and dyslipidemia in one case: first report of a Syrian familyOxford Medical Case Reports, 2021
- Insights from the clinical phenotype of subjects with Laron syndrome in EcuadorReviews in Endocrine and Metabolic Disorders, 2020
- Laron syndrome – A historical perspectiveReviews in Endocrine and Metabolic Disorders, 2020
- Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patientsEuropean Journal of Human Genetics, 2019
- CARE guidelines for case reports: explanation and elaboration documentJournal of Clinical Epidemiology, 2017
- Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients—From discovery to treatmentGrowth Hormone & IGF Research, 2016
- Head circumference in untreated and IGF-I treated patients with Laron syndromeGrowth Hormone & IGF Research, 2012
- Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity)Clinical Endocrinology, 2006
- Growth curves for Laron syndrome.Archives of Disease in Childhood, 1993
- Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfectaAmerican Journal of Medical Genetics, 1993